Bone Marrow Transplant in MDS and AML
Bone marrow transplant (BMT) is currently the only curative treatment for AML and MDS patients. What does "curative treatment" mean? Who qualifies for BMT? When in treatment is BMT an option? Get the answers to these questions and more when Dr. Nandita Khera joins us to talk all things BMT.
Mary introduces the agenda for the event and featured speaker Dr. Nandita Khera.
Dr. Nandita Khera talks about bone marrow transplant.
Type your questions in the chat and we will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Nandita Khera, MD, MPH
Dr. Khera is a hematologist oncologist and Associate Professor of Medicine at the Mayo Clinic in Scottsdale, Arizona. The goal of Dr. Khera's research is to better inform and prepare patients for the psychosocial and financial consequences of treatment irrespective of their sociodemographic profile.